Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Rennard, B. Delafont, N. Locantore, A. Agusti, P. Calverley, E. Silverman, R. Tal-Singer, J. Vestbo (Omaha, Durham, Boston, Philadelphia, United States Of America; Paris, France; Barcelona, Spain; Liverpool, United Kingdom; Copenhagen, Denmark). Determination of COPD characteristics via unsupervised clustering of the ECLIPSE cohort. Eur Respir J 2011; 38: Suppl. 55, 4161

Member's Comments

No comment yet.

Related content which might interest you: Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort Source: Eur Respir J 2013; 42: 636-646 Year: 2013 A comparison of COPD patients with and without ACOS in the ECLIPSE study Source: Eur Respir J 2016; 47:1559-1562 Year: 2016 Identification of distinct trajectories of FEV1 progression in the ECLIPSE cohort Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine Year: 2021 SGRQ-C distribution in the evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) cohort: Characteristics of COPD subjects with extreme score quintiles Source: Annual Congress 2010 - COPD: symptoms and staging Year: 2010 Estimation of a disease progression model for COPD using data from the ECLIPSE study Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013 External validation of two prognostic scores predicting exacerbations in ECLIPSE COPD patients Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities Year: 2020 Metabolomic analysis of severe COPD. Study of biomarkers in the CHAIN cohort. Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 LSC Abstract – Multi-level differential network analysis of COPD exacerbations Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Heterogeneity in the clinical outcomes of COPD: lessons from the ECLIPSE study Source: International Congress 2017 – Heterogeneity in COPD inflammation: implications for therapy and clinical outcomes Year: 2017 Clinically important results of phenotyping and endotyping of COPD: the ECLIPSE study Source: Annual Congress 2012 - PG14 From phenotypes to endotypes of asthma and COPD Year: 2012 Distribution of a COPD population based on the GOLD assessment framework Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort Source: Eur Respir J, 57 (3) 2001339; 10.1183/13993003.01339-2020 Year: 2021 Longitudinal validation of clinical COPD phenotypes identified by cluster analysis Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Distribution of T2 markers in real-life patients with asthma, COPD and asthma+COPD from the BREATHE study Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Detecting specific clusters of asthma and COPD patients using fluctuation based clustering of daily lung function recordings in the BIOAIR study Source: International Congress 2015 – Any news from the asthma field? Year: 2015 Blood biomarkers in COPD: results from the ECLIPSE (evaluation of COPD longitudinally to identify predictive surrogate endpoints) cohort Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD Year: 2009 Factors associated with prolonged duration of AECOPD:Analysis of the ECLIPSE cohort Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Combining supervised and unsupervised models to characterize asthma phenotypes in children Source: International Congress 2018 – Insights in primary ciliary dyskinesia, asthma and lung function testing Year: 2018 Association of testosterone level with phenotypic characteristics and long-term outcomes of men with COPD in the ECLIPSE cohort Source: Annual Congress 2011 - COPD: mechanisms and biomarker Year: 2011 One-year exacerbation frequency and treatment in the ECLIPSE study cohort Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009